BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
Johnson & Johnson Withdraws Controversial 340B Rebate Plan Following HRSA's Warning October 2, 2024 Johnson & Johnson (J&J) has abandoned its contentious plan to replace upfront 340B drug discounts with a rebate model following warnings from the Health Resources and Services Administration (HRSA).
Johnson & Johnson to Acquire Israeli Medtech Firm V-Wave for Up to $1.7 Bn August 21, 2024 Johnson & Johnson had previously invested in V-Wave in 2016, signaling a long-standing interest in the company's innovative technologies.
Ireland’s Janssen to be Branded as Johnson & Johnson June 24, 2024 The company stated that these changes are part of a global rebranding initiative with the updated brand gradually being applied to all company materials, product packaging, and branding assets.
Bansal Eye Hospital Unveils Advanced SILK Laser Vision Correction Technology in Ambala June 17, 2024 Ambala’s Bansal Eye Hospital has launched the advanced SILK (Smooth Incisions Lenticule Keratomileusis) laser vision correction technology.
Johnson & Johnson to Acquire Shockwave Medical for $13.1 Bn April 8, 2024 With this acquisition, Johnson & Johnson aims to bolster its position in cardiovascular intervention, one of the fastest-growing global medtech markets.
Page 1 of 1
